pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 13·1 min read
save

STAT+ probes Commure’s AI-driven health-care platform and Medicare’s new incentives for AI medical devices

Aug 13, 2026·read at STAT ↗Neutral

The STAT Health Tech newsletter edition dated Aug 13, 2026 features an investigative piece on Commure, a General Catalyst-backed firm that claims to automate health-care operations using artificial intelligence.

The report also examines recent Medicare policies that introduce new technology incentives aimed at encouraging the development and use of AI-enabled medical devices.

The article notes that the newsletter will pause for a summer break and return on Aug 25, and it is available to STAT+ subscribers with a paid subscription model.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices”

read at STAT ↗
454 words · retrieved Aug 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1d agoOpinion: I worked on the CDC investigation of the anthrax letters. 25 years later, are we ready for the next biothreat?STAT
  • 1d agoTrump administration uses rare authority to claw back nearly $1B in spending approved by CongressSTAT
  • 2d agoSTAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemicSTAT
  • 2d agoSTAT+: Lilly wins approval for once-weekly insulin shotSTAT
  • 2d agoOpinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drugSTAT